Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17912140.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Three boys with muscular dystrophy with known osteoporosis were each treated for 1 yr with weekly alendronate and daily calcium and vitamin D. Measurements of lumbar spine and proximal femur using dual-energy x-ray absorptiometry were obtained at the initiation of the alendronate, at 6 mos, and at 1 yr. All three boys demonstrated increases in bone mineral density, with z scores improving from baseline to 1-yr follow-up. Improvements were observed at the lumbar spine, femoral neck, and greater trochanter. In this small case series, weekly oral alendronate for 1 yr plus daily vitamin D and calcium was effective in improving bone mineral density.
Medical subject headings
- Alendronate
- Bone Density Conservation Agents
- Diphosphonates
- Muscular Dystrophies
- Osteoporosis